Efficacy and safety of cotadutide, a dual GLP-1 and glucagon receptor agonist, for patients with type 2 diabetes mellitus and CKD

Category Primary study
JournalJournal of the American Society of Nephrology
Year 2020
This article has no abstract
Epistemonikos ID: 2d12569aeb392b7d64d1d9b27be8f4c6e910e30d
First added on: Feb 12, 2025